Radiofrequency currents exert cytotoxic effects in NB69 human neuroblastoma cells but not in peripheral blood mononuclear cells

Hernández-Bule,María  Luisa; Roldán,Ernesto; Matilla,Joaquín; Trillo,María  Ángeles; Úbeda,Alejandro

doi:10.3892/ijo.2012.1569

Radiofrequency currents exert cytotoxic effects in NB69 human neuroblastoma cells but not in peripheral blood mononuclear cells

Authors:
- María Luisa Hernández-Bule
- Ernesto Roldán
- Joaquín Matilla
- María Ángeles Trillo
- Alejandro Úbeda
View Affiliations

Affiliations: Department of Research-BEM-IRYCIS, Hospital Ramon y Cajal, 28034 Madrid, Spain, Clinical Immunology, Cellular and Tumoral Immunology Section, Hospital Ramon y Cajal, 28034 Madrid, Spain, Research-Biochemistry-IRYCIS, Hospital Ramon y Cajal, 28034 Madrid, Spain
Published online on: July 24, 2012 https://doi.org/10.3892/ijo.2012.1569
Pages: 1251-1259
Copyright: © Hernández-Bule et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recently, a number of electric and electrothermal therapies have been applied to the treatment of specific cancer types. However, the cellular and molecular mechanisms involved in the response to such therapies have not been well characterized yet. Capacitive-resistive electric transfer (CRET) therapy uses electric currents at frequencies within the 0.45-0.6 MHz range to induce hyperthermia in target tissues. Preliminary trials in cancer patients have shown consistent signs that CRET could slow down growth of tumor tissues in brain gliomas, without inducing detectable damage in the surrounding healthy tissue. Previous studies by our group have shown that subthermal treatment with 0.57-MHz electric currents can induce a cytostatic, not cytotoxic response in HepG2 human hepatocarcinoma cells; such effect being mediated by cell cycle alterations. In contrast, the study of the response of NB69 human neuroblastoma cells to the same electric treatment revealed consistent indications of cytotoxic effects. The present study extends the knowledge on the response of NB69 cells to the subthermal stimulus, comparing it to that of primary cultures of human peripheral blood mononuclear cells (PBMC) exposed to the same treatment. The results showed no sensitivity of PBMC to the 0.57 MHz subthermal currents and confirmed that the treatment exerts a cytotoxic action in NB69 cells. The data also revealed a previously undetected cytostatic response of the neuroblastoma cell line. CRET currents affected NB69 cell proliferation by significantly reducing the fraction of cells in the phase G2/M of the cell cycle at 12 h of exposure. These data provide new information on the mechanisms of response to CRET therapy, and are consistent with a cytotoxic and/or cytostatic action of the electric treatment, which would affect human cells of tumor origin but not normal cells with a low proliferation rate.

View Figures

View References

1	Ottawa Panel: Ottawa panel evidence based clinical practice guidelines for electrotherapy and thermotherapy interventions in the management of rheumatoid arthritis in adults. Phys Ther. 84:1016–1043. 2004.
2	Ricci NA, Dias CN and Driusso P: The use of electrothermal and phototherapeutic methods for the treatment of fibromyalgia syndrome: a systematic review. Rev Bras Fisioter. 14:1–9. 2010.PubMed/NCBI
3	Sersa G, Jarm T, Kotnit T, Koer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranic S, Secerov A and Cemazar M: Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer. 98:388–398. 2008. View Article : Google Scholar : PubMed/NCBI
4	Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzhaki A, Mordechovich D, Steinberg-Shapira S, Gurvich Z, Shneiderman R, et al: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci USA. 107:10152–10157. 2007. View Article : Google Scholar : PubMed/NCBI
5	Garon EB, Sawcer D, Vernier PT, Tang T, Sun Y, Marcu L, Gundersen MA and Koeffler HP: In vitro and in vivo evaluation and a case report of intense nanosecond pulsed electric field as a local therapy for human malignancies. Int J Cancer. 121:675–682. 2007. View Article : Google Scholar : PubMed/NCBI
6	Fiorentini G, Giovanis P, Rossi S, Dentico P, Paola R, Turrisi G and Bernardeschi P: A phase II clinical study on relapsed malignant gliomas treated with electro-hyperthermia. In Vivo. 20:721–724. 2006.PubMed/NCBI
7	Kamisawa T, Tu Y, Egawa N, Karasawa K, Matsuda T, Tsuruta K and Okamoto A: Thermo-chemo-radiotherapy for advanced bile duct carcinoma. World J Gastroenterol. 11:4206–4209. 2005.PubMed/NCBI
8	Grimnes S and Martinsen ØG: Joule effect and temperature rise. Bioimpedance and Bioelectricity Basics. Academic Press: Harcourt and Technology Co.; London: pp. 71–73. 2000
9	Ley A, Cladellas M, Colet P, de las Heras P, Florensa J, Prim J, Roussos J, Ariza A and Calbet J: Transferencia eléctrica capacitiva (TEC): Técnica no invasiva de hipertermia profunda en el tratamiento de los gliomas cerebrales. Resultados preliminares. Neurocirugía. 3:118–123. 1992.(In Spanish).
10	Ley A, Ariza A and Rosell R: Tratamiento quirúrgico de los gliomas malignos. Hipertermia. Tumores del Sistema Nervioso Central. Epidemiologia, Nosología y Terapéutica, Doyma: Barcelona: pp. 55–64. 1993, (In Spanish).
11	Ley A: Hipertermia intracraneal no invasiva mediante la técnica de Transferencia Eléctrica Capacitiva (TEC). Resultados de la termometría cerebral e intratumoral. Neurocirugía. 14:41–45. 2003.(In Spanish).
12	Sakamoto T, Katoh H, Shimizu T, Yamashita I, Takemori S, Tazawa K and Fujimaki M: Clinical results of treatment of advanced carcinoma with hyperthermia in combination with chemoradiotherapy. Chest. 112:1487–1493. 1997. View Article : Google Scholar : PubMed/NCBI
13	Matsui Y, Nakagana A, Kamiyama Y, Yamamoto K, Kubo N and Nakase Y: Selective thermocoagulation of unresectable pancreatic cancers by using radiofrequency capacitive heating. Pancreas. 20:14–20. 2000. View Article : Google Scholar : PubMed/NCBI
14	Ohguri T, Imada H, Yahara K, Kakeda S, Tomimatsu A, Kato F, Nomoto S, Terashima H and Korogi Y: Effect of 8-MHz radiofrequency-capacitive regional hyperthermia with strong superficial cooling for unresectable or recurrent colorectal cancer. Int J Hyperthermia. 20:465–475. 2004. View Article : Google Scholar
15	Hernández-Bule ML, Trillo MA, Bazán E, Martínez-Pascual MA, Leal J and Úbeda A: Niveles atérmicos de corrientes eléctricas usadas en terapia por transferencia eléctrica capacitiva inducen efectos citotóxicos parciales en cultivos de neuroblastoma humano. Neurocirugía. 15:366–371. 2004.(In Spanish).
16	Hernández-Bule ML, Trillo MA, Cid MA, Leal J and Ubeda A: In vitro exposure to 0.57 MHz electric currents exerts cytostatic effects in HepG2 human hepatocarcinoma cells. Int J Oncol. 30:583–592. 2007.
17	Hernández-Bule ML, Cid MA, Trillo MA, Leal J and Ubeda A: Cytostatic response of HepG2 to 0.57 MHz electric currents mediated by changes in cell cycle control proteins. Int J Oncol. 37:1399–1405. 2010.PubMed/NCBI
18	Wang E, Yin Y, Zhao M, Forrester JV and McCaig CD: Physiological electric fields control the G1/S phase cell cycle checkpoint to inhibit endothelial cell proliferation. FASEB J. 17:458–460. 2003.PubMed/NCBI
19	Kirson ED, Gurvich Z, Shneiderman R, Dekel E, Itzhaki A, Wasserman Y, Schatzberger R and Palti Y: Disruption of cancer cell replication by alternating electric fields. Cancer Res. 64:3288–3295. 2004. View Article : Google Scholar : PubMed/NCBI
20	Boyum A: Isolation of leucocytes from human blood. A two-phase system for removal of red cells with methylcellulose as erythrocyte-aggregating agent. Scand J Clin Lab Invest (Suppl). 97:9–29. 1968.PubMed/NCBI
21	Rodríguez-Martín E, Canals S, Casarejos MJ, de Bernardo S, Handler A and Mena MA: L-DOPA and glia-conditioned medium have additive effects on tyrosine hydroxylase expression in human catecholamine-rich neuroblastoma NB69 cells. J Neurochem. 78:535–545. 2001.PubMed/NCBI
22	Kato S, Asada R, Kageyama K, Saitoh Y and Miwa N: Anticancer effects of 6-O-palmitoyl-ascorbate combined with a capacitive-resistive electric transfer hyperthermic apparatus as compared with ascorbate in relation to ascorbyl radical generation. Cytotechnology. 63:425–435. 2011. View Article : Google Scholar
23	Aslan JE and Thomas G: Death by committee: organellar trafficking and communication in apoptosis. Traffic. 10:1390–1404. 2009. View Article : Google Scholar : PubMed/NCBI
24	Woods AL, Hall PA, Shepherd NA, Hanby AM, Waseem NH, Lane DP and Levison DA: The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis. Histophatology. 19:21–27. 1991.
25	Connolly KM and Bogdanffy MS: Evaluation of proliferating cell nuclear antigen (PCNA) as an endogenous marker of cell proliferation in rat liver: a dual-stain comparison with 5-bromo-2′-deoxyuridine. J Histochem Cytochem. 41:1–6. 1993.PubMed/NCBI
26	Nakano A, Norihito W, Yasuhiro N, Takashimizu S and Matsuzaki S: Immunohistochemical studies on the expression of P-glycoprotein and p53 in relation to histological differentiation and cell proliferation in hepatocellular carcinoma. Hepatol Res. 25:158–165. 2003. View Article : Google Scholar : PubMed/NCBI
27	Feder MK and Gilbert F: Clonal evolution in a human neuroblastoma. J Natl Cancer Inst. 70:1051–1056. 1983.PubMed/NCBI
28	Acosta S, Lavarino C, Paris R, García I, de Torres C, Rodríguez E, Beleta H and Mora J: Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells. BMC Dev Biol. 12:9–12. 2009.PubMed/NCBI